To further identify that circSEMA4B functions as a tumor suppressor mainly through PI3K/Akt pathway, we exploit whether Akt inhibitor MK2206 recapitulates the effect of circSEMA4B overexpression in repressing the malignant phenotypes of BC cells. This evidence concerns the gene AKT1 and breast cancer.